As a US lawyer and English solicitor, Charles (Chuck) Larsen provides clients sophisticated multijurisdictional counsel in intellectual property portfolio strategy, transactions and disputes, with a particular emphasis in bioengineering and the medical technology space. He is licensed to practice before the US Patent and Trademark Office (USPTO), the European Patent Office (EPO), US District Court, and the courts of England and Wales.
He conducts IP due diligence in the US and Europe with an emphasis on transatlantic patent validity, infringement and freedom to operate studies. He actively supports clients in US and European patent disputes including Patent Trial and Appeal Board (PTAB) proceedings, reexams, EPO oppositions and litigation.
Chuck also has extensive experience in transactional IP matters, including transaction structuring and portfolio due diligence for investments and acquisitions, and negotiating collaboration license agreements, joint ventures and other strategic commercial contracts involving key IP assets.
Chuck has advised on a wide range of technology in engineering and life sciences, including bioengineering and medical technology, pharmaceuticals, microfluidics, drug delivery, machine learning, signal processing, combustion and energy. In the medical technology sector, his experience has involved a wide range of technologies, including intravascular devices, respiratory systems, orthopedic implants, cellular therapy, tissue engineering, neuromonitoring, spine technology, electrical stimulation, healthcare informatics, DNA sequencing, software driven devices, biological manufacturing and diagnostics.
